» Articles » PMID: 7526001

The Significance of Isoechoic Prostatic Carcinoma

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 1994 Dec 1
PMID 7526001
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The diagnosis of prostatic carcinoma is most commonly made today by transrectal ultrasound guided needle biopsy. Often hypoechoic and peripheral zone lesions are the only areas sampled. Recently, we showed that this approach missed a quarter of the cancers that would be detected by a systematic biopsy technique. We term these missed cancers isoechoic carcinomas. We reviewed 1,549 systematic sextant prostate needle biopsies, of which 417 cancers were detected and subdivided into hypoechoic cancers (cancers detected on biopsy of a hypoechoic sector and isoechoic cancers (cancers found only in normal [isoechoic] peripheral zone). We noted in men with only isoechoic cancers that fewer biopsy cores per prostate revealed cancer (mean 1.6 versus 3.0, p < 0.0001) and that these men had lower serum prostate specific antigen levels (mean 14.4 versus 43.7, p < 0.001). The Gleason scores for the isoechoic and hypoechoic cancers were indistinguishable. The pathological staging of hypoechoic and isoechoic cancers was also similar. This study suggests that while isoechoic cancers are generally smaller than hypoechoic cancers, they do not represent low grade clinically insignificant carcinomas. A systematic approach to performing prostate biopsy is recommended.

Citing Articles

How to Improve TRUS-Guided Target Biopsy following Prostate MRI.

Park B Cancers (Basel). 2021; 13(22).

PMID: 34830798 PMC: 8616137. DOI: 10.3390/cancers13225647.


Multiparametric MRI fusion-guided prostate biopsy in biopsy naive patients: Preliminary results from 80 patients.

Sonmez G, Tombul S, Imamoglu H, Akgun H, Demirtas A, Tatlisen A Turk J Urol. 2019; 45(3):196-201.

PMID: 30817279 PMC: 6469728. DOI: 10.5152/tud.2019.03710.


The predictive efficacy of hypoechoic lesion in ultrasound for prostate cancer in Chinese people: five-year experience in a moderated 10-core transperineal prostate biopsy procedure.

Yang T, Zhang L, Chen Y, Cai Y, Jiang H, Ding Q Oncotarget. 2017; 8(45):79433-79440.

PMID: 29108322 PMC: 5668055. DOI: 10.18632/oncotarget.18342.


Multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy with semi-robotic navigation in the Chinese population: initial results.

Ma W, Ho B, Lai A, Lam K, Chan Y, Yip L Asian J Androl. 2017; 20(1):93-94.

PMID: 28327476 PMC: 5753563. DOI: 10.4103/1008-682X.196855.


Prostate cancer detection and diagnosis: the role of MR and its comparison with other diagnostic modalities--a radiologist's perspective.

Penzkofer T, Tempany-Afdhal C NMR Biomed. 2013; 27(1):3-15.

PMID: 24000133 PMC: 3851933. DOI: 10.1002/nbm.3002.